Modulation of antigen processing and presentation by persistent virus infections and in tumors
- PMID: 9297529
- DOI: 10.1016/s0198-8859(97)00083-9
Modulation of antigen processing and presentation by persistent virus infections and in tumors
Abstract
Cell-mediated immunity is effective against cells harboring active virus replication and is critical for the elimination of ongoing infections, opposing tumor progression, and reducing or preventing the reactivation of persistent viruses and tumor metastasis. The capacity of persistent viruses and tumor cells to maintain a long-term relationship with their host presupposes mechanisms for circumventing antiviral or antitumor defenses. By suppressing the expression of molecules associated with antigen processing and presentation, abrogation of the major immune mechanism that deals with the elimination of infected and transformed cells is achieved. This is accomplished in tumors predominantly by transcriptional downregulation of genes encoding class I major histocompatibility complex antigens, peptide transporter molecules, and the proteasome-associated low molecular mass protease subunits, and in cells expressing viral proteins by interfering with peptide transport and the assembly/transport of class I complexes. In addition, virus-infected cells and selected tumor cells express mainly nonimmunogenic or antagonistic peptide epitopes. This review describes mechanisms used by viruses and in transformed cells for interference with antigen processing and presentation and addresses their significance for in vivo viral persistence and tumor progression.
Similar articles
-
Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation.Immunol Res. 1995;14(2):77-97. doi: 10.1007/BF02918170. Immunol Res. 1995. PMID: 8530879 Review.
-
Interference with antigen processing by viruses.Curr Opin Immunol. 1997 Aug;9(4):470-6. doi: 10.1016/s0952-7915(97)80097-0. Curr Opin Immunol. 1997. PMID: 9287180 Review.
-
Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation.Curr Top Microbiol Immunol. 2005;285:199-217. doi: 10.1007/3-540-26764-6_7. Curr Top Microbiol Immunol. 2005. PMID: 15609505 Review.
-
The effect of viruses on the ability to present antigens via the major histocompatibility complex.Microbes Infect. 1999 Apr;1(4):335-45. doi: 10.1016/s1286-4579(99)80029-x. Microbes Infect. 1999. PMID: 10602667 Review.
-
Viral interference with antigen presentation.Nat Immunol. 2002 Nov;3(11):1019-25. doi: 10.1038/ni1102-1019. Nat Immunol. 2002. PMID: 12407410 Review.
Cited by
-
IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response.Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9241-6. doi: 10.1073/pnas.0501711102. Epub 2005 Jun 8. Proc Natl Acad Sci U S A. 2005. PMID: 15944226 Free PMC article.
-
Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation.J Virol. 2007 Apr;81(8):4323-30. doi: 10.1128/JVI.02279-06. Epub 2007 Jan 31. J Virol. 2007. PMID: 17267477 Free PMC article.
-
Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage.J Virol. 2000 Dec;74(23):11304-10. doi: 10.1128/jvi.74.23.11304-11310.2000. J Virol. 2000. PMID: 11070030 Free PMC article.
-
Processing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes.Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):853-70. doi: 10.1177/039463200601900415. Int J Immunopathol Pharmacol. 2006. PMID: 17166407 Free PMC article.
-
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).J Exp Med. 1998 Nov 16;188(10):1841-8. doi: 10.1084/jem.188.10.1841. J Exp Med. 1998. PMID: 9815261 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
